Pregnant women injecting enoxaparin sodium injection has certain effects of fetal preservation as well as improving blood circulation.
For pregnant women in hypercoagulable state, enoxaparin sodium injection can avoid thrombogenic diseases, such as umbilical cord thrombosis, placental thrombosis, etc., and reduce the risk of fetal deformity and death; at the same time, enoxaparin sodium injection has an anticoagulant effect, which improves the uterine blood circulation, and helps to ensure the health of the pregnant woman and the fetus.
It should be noted that enoxaparin needs to be fully assessed before use to exclude contraindications, such as bleeding or severe coagulation disorder-related bleeding, patients with a history of severe type II heparin-induced thrombocytopenia, active peptic ulcers or organ injuries with a tendency to bleed, as well as clinically significant active hemorrhage, cerebral hemorrhage, and severe renal failure.
Injections of enoxaparin sodium injection for pregnant women should be handled by professionals, and if any discomfort arises after the injection, it is recommended to inform the healthcare personnel immediately and be handled by professional doctors.